Selected Stock Price Target News of the Day — May 14, 2026

Today’s stock price target news covers three distinct stories from Thursday’s session. Doximity drew twelve separate analyst actions after fiscal Q4 results produced a forward guidance miss. Goldman Sachs moved Whirlpool from Buy to Neutral as the appliance maker faces persistent housing-related headwinds. BTIG raised the CrowdStrike price target by $122 following a channel survey with ten industry contacts ahead of the company’s upcoming earnings report.

Doximity Stock Price Target News: Twelve Analyst Actions Follow FY27 Guidance Miss

Doximity reported fiscal Q4 2026 revenue of $145 million, up 5% year over year. The result beat the high end of management’s own guidance range for the quarter. Full-year fiscal 2026 revenue reached $645 million, representing 13% growth over the prior year. Free cash flow for the quarter reached $107 million, and annual free cash flow for fiscal 2026 hit $317 million. The company’s fiscal 2027 revenue guidance of $664 million to $676 million, however, disappointed Wall Street. The midpoint of that range fell approximately 3% below the consensus estimate of $697 million. Doximity projected first-quarter fiscal 2027 revenue between $151 million and $152 million, implying about 4% year-over-year growth at the midpoint. The company cited softer pharmaceutical advertising visibility and planned AI infrastructure investment as drivers of the cautious outlook.

Wells Fargo analyst Stan Berenshteyn moved Doximity from Overweight to Equal Weight on Thursday morning. Berenshteyn carries a 57.92% hit rate across 101 closed price target forecasts on AnaChart. BTIG analyst David Larsen issued a concurrent downgrade, cutting his rating from Buy to Neutral. AnaChart tracks Larsen’s 45.8% hit rate across 269 forecasts in his coverage history. KeyBanc analyst Scott Schoenhaus also removed his Overweight rating on Doximity, moving the stock to Sector Weight. Schoenhaus carries a 48.57% hit rate across 169 price target calls on AnaChart.

Baird analyst Vikram Kesavabhotla issued the sharpest price target cut among Thursday’s downgraders. He moved Doximity from Outperform to Neutral and reduced the price target from $40 to $18. That represents a 55% reduction in his one-year price target in a single session. Kesavabhotla carries a 58.14% hit rate across 162 price target forecasts tracked by AnaChart. Raymond James analyst Brian Peterson also downgraded Doximity on Thursday. Peterson carries a 55.26% accuracy rate across 341 price target forecasts on AnaChart.

Analysts who maintained bullish ratings still cut their price targets by significant margins. Morgan Stanley‘s Ricky Goldwasser held an Overweight rating but lowered the price target from $49 to $35. Goldwasser carries a 71.18% hit rate across 380 price target forecasts on AnaChart. Needham analyst Scott Berg cut his price target from $55 to $27 while maintaining a Buy rating. Berg has a 46.89% hit rate across 856 price target forecasts, one of the largest tracked sample sizes in the sector. Mizuho analyst Steven Valiquette lowered the Doximity price target to $26.

Goldman Sachs analyst David Roman reduced his price target to $24 following the earnings report. Evercore ISI analyst Elizabeth Anderson cut her target to $19. Anderson carries a 51.24% hit rate across 240 forecasts tracked by AnaChart. BMO Capital also lowered its Doximity price target to $20 in Thursday morning coverage.

Piper Sandler analyst Sean Wieland offered a contrasting view on Thursday. Wieland reiterated an Overweight rating and a $42 price target on Doximity. He characterized the post-earnings reaction as a buyer’s opportunity, per StreetInsider coverage of his note. Wieland carries a 69.55% hit rate across 366 price target forecasts on AnaChart.

Doximity reported that more than 800,000 active prescribers used its workflow tools in the fourth quarter. AI prompt activity inside the company’s Clinical AI Suite nearly doubled from January to April 2026. CEO Jeff Tangney highlighted that engagement trend as a long-term growth driver independent of pharmaceutical advertising cycles. The company’s physician network spans more than 80% of U.S. physicians, providing a defensible distribution base for future product expansion. The softer pharma advertising environment is an industry-wide dynamic tied to drug pricing reform discussions and a pullback in direct-to-physician promotional spending.

Goldman Sachs Cuts Whirlpool to Neutral on Appliance Demand Outlook

Goldman Sachs analyst Samuel Eisner downgraded Whirlpool from Buy to Neutral on Thursday. Eisner also lowered his price target from $72 to $53, a reduction of 26.4%. The revised $53 target sits below the stock’s current trading level near $58, indicating Eisner sees near-term downside risk from current prices. He cited rising inflation since late February as a headwind for appliance demand. Existing home sales are currently running approximately 25% below the 2015 to 2019 average, per Eisner’s analysis. That gap limits the volume of discretionary appliance purchases typically tied to home transactions. Goldman Sachs expects existing home sales to remain near 4 million units annually through 2026 and 2027. Elevated mortgage rates are the primary constraint keeping home turnover at that depressed pace. AnaChart tracks Eisner’s 100% hit rate across 24 closed price target forecasts.

Whirlpool reported Q1 2026 results in late April that fell short of analyst expectations on both earnings and revenue. The company posted a first-quarter EPS loss of $0.56, missing the consensus estimate of $0.62. Revenue of $3.27 billion for the quarter came in below the $3.51 billion Wall Street consensus. Reduced appliance volumes as fewer homes change hands and consumers defer high-ticket replacement purchases were the primary drivers of the shortfall. Whirlpool shares have declined approximately 47% over the past twelve months. The stock currently trades near its 52-week low as the appliance industry faces both pricing pressure and volume constraints simultaneously.

BTIG Raises CrowdStrike Price Target on Platform Consolidation

BTIG analyst Gray Powell raised the CrowdStrike price target from $499 to $621 on Thursday, maintaining a Buy rating on the cybersecurity platform. Powell spoke with ten contacts ahead of CrowdStrike’s upcoming fiscal first quarter earnings report. Those contacts included six channel partners and four independent industry analysts. The six partners collectively represent approximately $700 million in combined annual CrowdStrike sales. Two of those six partners increased their CrowdStrike growth expectations compared to BTIG’s January-quarter channel survey. AnaChart tracks Powell’s 69.1% hit rate across 281 closed price target forecasts.

Powell noted that the platform consolidation narrative is increasingly resonating with enterprise security buyers. He described headwinds from the standalone endpoint security market as more than offset by accelerating adoption of CrowdStrike’s broader platform modules. CrowdStrike has positioned itself as a unified security solution for enterprise clients seeking to consolidate multiple point products. That model covers endpoint, cloud workloads, identity protection, and threat intelligence under a single vendor contract. The approach reduces vendor complexity and total cost of ownership, an argument that enterprise security teams have embraced as security budgets face tighter scrutiny. Powell’s channel data suggests that message is gaining measurable traction across enterprise accounts. The upcoming earnings report will test whether that channel optimism translates into reported net new annual recurring revenue and module attach rates.

This morning’s stock price target news reflects three different analytical frameworks operating across three sectors. Doximity’s situation is a guidance-revision story that produced a broad institutional reassessment within a single trading session. Whirlpool’s case illustrates how macroeconomic headwinds in the housing market continue to constrain established consumer durables businesses, even after earnings have already been reported. CrowdStrike’s raise demonstrates how systematic channel checks ahead of earnings can surface conviction before the official numbers arrive. The full price target history for DOCS, WHR, and CRWD, along with the track record of every analyst and firm named here, lives in the analyst price target dataset. It covers 661,383 price targets and 759,654 ratings from 7,191 analysts (3,754 active, 3,437 retired), across 9,686 tickers and 424 brokers (333 active), spanning 2008 to 2026.